Patients using SGLT2i preoperatively have a slightly increased risk for postoperative euglycemic ketoacidosis but a lower risk for AKI and mortality.

Reductions in alcohol intake were noted in high and low consumers; no significant difference was seen in percentage reductions for men and women.

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

Maternal obesity and hypothyroxinemia were independently and synergistically associated with increased risk for large for gestational age.

Oocyte retrieval outcomes were similar between patients with a BMI of at least 45 kg/m2 and patients with BMI of 40 to 44.9 kg/m2.

The FDA has approved Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced, unresectable, or metastatic PPGL.

Weight gain combined with late first pregnancy or nulliparity is associated with an increased risk for breast cancer.

Simultaneous liver transplant and sleeve gastrectomy yield durable weight loss, resolution of diabetes and hypertension, and a reduction in allograft steatosis development.

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

Thyroid cancer-associated syndromes, including multiple endocrine neoplasia type 2, were significantly more prevalent than current estimates.

Individuals with type 1 (T1D) and type 2 diabetes have a higher risk for ischemic stroke, but those with T1D also have a higher risk for hemorrhagic stroke.